tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Algorae Pharmaceuticals Reports Reduced Losses and Increased Revenue

Story Highlights
Algorae Pharmaceuticals Reports Reduced Losses and Increased Revenue

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Living Cell Technologies ( (AU:1AI) ) has shared an announcement.

Algorae Pharmaceuticals Limited reported a 13% increase in total revenue and other income for the year ended June 30, 2025, reaching $141,050. The company also saw a significant reduction in net loss after tax, which decreased by 62% to $802,958, primarily due to an R&D tax refund, decreased share-based payments, increased interest on funds, and lower administration expenses. No dividends were declared for the current or previous financial periods.

More about Living Cell Technologies

Technical Sentiment Signal: Strong Sell

Current Market Cap: A$13.5M

Learn more about 1AI stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1